PMID: 42466348

Incretin-based cardiovascular protection beyond diabetes: evidence, mechanisms, and therapeutic frontiers from GLP-1 receptor agonists to multi-agonist therapy.

Qiu Libin, Liu Jinpeng, Hu Nana

Frontiers in endocrinology · 2026

Vol. 17, pp. 1870649

View on PubMedDOI

This entry links to third-party literature. For research use only.

HumansIncretinsGlucagon-Like Peptide-1 Receptor AgonistsCardiovascular DiseasesDiabetes Mellitus, Type 2Hypoglycemic AgentsSemaglutide

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.